Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | NPC1 | O15118 | 9/20 | 0.59 |
| ▸ | RAB9A | P51151 | 9/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.59 |
| ▸ | RELA | Q04206 | 1/20 | 0.59 |
| ▸ | NR1H4 | Q96RI1 | 4/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 3/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.54 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.54 |
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | PLK1 | P53350 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2618872 | 0.94 | L3MBTL1 (0.67) | L3MBTL1NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL13167090 | 0.91 | L3MBTL1 (0.80) | L3MBTL1NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL13167094 | 0.89 | L3MBTL1 (0.77) | L3MBTL1NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL13415303 | 0.87 | LMNA (0.67) | L3MBTL1NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL13415301 | 0.86 | L3MBTL1 (0.69) | L3MBTL1NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL10192395 | 0.86 | L3MBTL1 (0.83) | L3MBTL1NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL2618505 | 0.84 | L3MBTL1 (0.86) | L3MBTL1NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL13167415 | 0.84 | L3MBTL1 (0.86) | L3MBTL1NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL16579414 | 0.84 | L3MBTL1 (0.86) | L3MBTL1NPC1RAB9ANFKB1NFKB2 | |
| SCHEMBL2618901 | 0.83 | LMNA (0.66) | L3MBTL1NPC1RAB9ANFKB1NFKB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9316843-B2 | Stereoscopic image recognition apparatus | FUJIFILM CORPORATION (JP) | 2016-04-19 | — | — | US | disclosed |
| US-20150080582-A1 | OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND | FUJIFILM CORPORATION (JP) | 2015-03-19 | — | — | US | disclosed |
| US-8981108-B2 | Optical film, retardation plate, elliptica polarizing plate, liquid crystal display device and compound | FUJIFILM CORPORATION (JP) | 2015-03-17 | — | — | US | disclosed |
| US-8842243-B2 | IPS or FFS-mode liquid-crystal display device | FUJIFILM CORPORATION (JP) | 2014-09-23 | — | — | US | disclosed |
| US-20120194767-A1 | IPS OR FFS-MODE LIQUID-CRYSTAL DISPLAY DEVICE | FUJIFILM CORPORATION (JP) | 2012-08-02 | — | — | US | disclosed |
| US-20120099033-A1 | STEREOSCOPIC IMAGE RECOGNITION APPARATUS | FUJIFILM CORPORATION (JP) | 2012-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080582-A1 | OPTICAL FILM, RETARDATION PLATE, ELLIPTICA POLARIZING PLATE, LIQUID CRYSTAL DISPLAY DEVICE AND COMPOUND | PYM1, CCND2, CCNB2 | L3MBTL1 101/4885NPC1 4454/4885RAB9A 1682/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.